Elevated Serum Vitamin B₁₂ Levels as a Prognostic Factor for Survival Time in Metastatic Cancer Patients: A Retrospective Study

References

• Folprecht G, Seymour MT, Saltz L, Douillard JY, Hecker H, et al.: Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials. J ClinOncol 20, 1443–1451, 2008.
   Web of Science ®Google Scholar
• Jatoi A, Foster NR, Egner JR, Burch PA, Stella PJ, et al.: Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophagealjunction, and stomach: a pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials. Int J Oncol 36, 601–606, 2010.
   PubMed Web of Science ®Google Scholar
• Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, et al.: Relationship between cancer patients'predictions of prognosis and their treatment preferences. JAMA 279, 1709–1714, 1998.
   PubMed Web of Science ®Google Scholar
• Glare P, Virik K, Jones M, Hudson M, Eychmuller S, et al.: A systematic review of physicians' survival predictions in terminally ill cancer patients. BMJ 327, 195–198, 2003.
   PubMed Web of Science ®Google Scholar
• Hamaker ME, Seynaeve C, Wymenga AN, van Tinteren H, Nortier JW, et al.: Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch breast cancer trialists' group. Breast 23, 81–87, 2014.
   PubMed Web of Science ®Google Scholar
• den Daas N: Estimating length of survival in end-stage cancer: a review of the literature. J Pain Symptom Manage 10, 548–555, 1995.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Kim SJ, Lee JK, Choi WS, Park JH, et al.: Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosis. J Cancer Res ClinOncol 140, 1567–1574, 2014.
   PubMed Web of Science ®Google Scholar
• Reuben DB, Mor V, and Hiris J: Clinical symptoms and length of survival in patients with terminal cancer. Arch Intern Med 148, 1586–1591, 1988.
   PubMed Web of Science ®Google Scholar
• Caraceni A, Nanni O, Maltoni M, Piva L, Indelli M, et al.: Impact of delirium on the short term prognosis of advanced cancer patients: Italian multicenter and study group on palliative care. Cancer 89, 1145–1149, 2000.
   PubMed Web of Science ®Google Scholar
• Bruera E, Miller MJ, Kuehn N, MacEachern T, and Hanson J: Estimate of survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manage 7, 82–86, 1992.
   PubMed Web of Science ®Google Scholar
• Maltoni M, Pirovano M, Nanni O, Marinari M, Indelli M, et al.: Biological indices predictive of survival in 519 Italian terminally ill cancerpatients. Italian multicenter study group on palliative care. J Pain Symptom Manage 13, 1–9, 1997.
   PubMed Web of Science ®Google Scholar
• Frydenberg H, Thune I, Lofterød T, Mortensen ES, Eggen AE, et al.: Pre-diagnostic high-sensitive C-reactive protein and breast cancer risk, recurrence, and survival. Breast Cancer Res Treat 155, 345–354, 2016.
   PubMed Web of Science ®Google Scholar
• Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, et al.: Prognostic factors in advanced cancer patients: evidence-based clinical recommendations—a study by the steering committee of the european association for palliative care. J ClinOncol 23, 6240–6248, 2005.
   PubMed Web of Science ®Google Scholar
• Mendis R, Soo WK, Zannino D, Michael N, and Spruyt O: Multidisciplinary prognostication using the palliative prognostic score in an Australian cancer center. Palliat Care 9, 7–14, 2015.
   PubMedGoogle Scholar
• Subramaniam S, Thorns A, Ridout M, Thirukkumaran T, and Osborne TR: Accuracy of prognosis prediction by PPI in hospice inpatients with cancer: a multi-centre prospective study. BMJ Support PalliatCare 5, 399–404, 2015.
   PubMed Web of Science ®Google Scholar
• Arendt JF, and Nexo E: Cobalamin related parameters and disease patterns in patients with increased serum cobalamin levels. PLoSOne 7, e45979, 2012. doi: 10.1371/journal.pone.0045979.
   PubMed Web of Science ®Google Scholar
• Arendt JF, and Nexo E: Unexpected high plasma cobalamin: proposal for a diagnostic strategy. ClinChem Lab Med 51, 489–496, 2013.
   Google Scholar
• Lin CY, Kuo CS, Lu CL, Wu MY, and Huang RF: Elevated serum vitamin B12 levels in association with tumor marker as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma. NutrCancer 62, 190–197, 2010.
   Google Scholar
• Kelly L, White S, and Stone PC: The B12/CRP index as a simple prognostic indicator in patients with advanced cancer: a confirmatory study. Ann Oncol 18, 1395–1399, 2007.
   PubMed Web of Science ®Google Scholar
• Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, et al.: Infectious diseases society of America: clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clin Infect Dis 52, e56–93, 2011. doi: 10.1093/cid/cir073.
   PubMed Web of Science ®Google Scholar
• Stabler SP: Clinical practice. Vitamin B12 deficiency. N Engl J Med 368, 149–160, 2013.
   PubMed Web of Science ®Google Scholar
• Chiche L, Jean R, Romain F, Roux F, Thomas G, et al.: Clinical implications of high cobalamin blood levels for internal medicine. Rev Med Interne 29, 187–194, 2008.
   PubMed Web of Science ®Google Scholar
• Andrès E, Serraj K, Zhu J, and Vermorken AJ: The pathophysiology of elevated vitamin B12 in clinical practice. QJM 106, 505–515, 2013.
   PubMed Web of Science ®Google Scholar
• Arendt JF, Pedersen L, Nexo E, and Sørensen HT: Elevated plasma vitamin B12 levels as a marker for cancer: a population-based cohort study. J Natl Cancer Inst 105, 1799–1805, 2013.
   PubMed Web of Science ®Google Scholar
• Arendt JF, Farkas DK, Pedersen L, Nexo E, and Sørensen HT: Elevated plasma vitamin B12 levels and cancer prognosis: a population-based cohort study. Cancer Epidemiol 40, 158–165, 2016.
   PubMed Web of Science ®Google Scholar
• Geissbühler P, Mermillod B, and Rapin CH: Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years. J Pain Symptom Manage 20, 93–103, 2000.
   PubMed Web of Science ®Google Scholar
• Tavares F: Is the B12/CRP Index more accurate than you at prediction life expectancy in advanced cancer patients? J Pain Symptom Manage 40, e12–13, 2010. doi: 10.1016/j.jpainsymman.2010.03.007.
   PubMedGoogle Scholar
• Smith RP, Lipworth BJ, Cree IA, Spiers EM, and Winter JH: C-reactive protein. a clinical marker in community-acquired pneumonia. Chest 108, 1288–1291, 1995.
   PubMed Web of Science ®Google Scholar
• Solomon LR: Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment. Blood Rev 21, 113–130, 2007.
   PubMed Web of Science ®Google Scholar
• Ermens AA, Vlasveld LT, and Lindemans J: Significance of elevated cobalamin (vitamin B12) levels in blood. Clin Biochem 36, 585–590, 2003.
   PubMed Web of Science ®Google Scholar
• Carmel R, and Eisenberg L: Serum vitamin B12 and transcobalamin abnormalities in patients with cancer. Cancer 40, 1348–1353, 1977.
   PubMed Web of Science ®Google Scholar